SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Oct-24 10:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Oct-24 | Private Sale (Planned) | 1,295 | $113.66 | $147,190.00 | (77%) 1.67K to 0.38K | |
15-Feb-24 5:33 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 1,811 | $133.07 | $240,996.00 | (27%) 6.71K to 4.89K | |
08-Feb-24 7:46 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-24 | Sale (Planned) | 1,328 | $135.41 | $179,830.00 | (21%) 6.22K to 4.89K | |
08-Feb-24 7:46 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-24 | Private Sale (Planned) | 456 | $141.96 | $64,733.80 | (9%) 5.35K to 4.89K | |
02-Feb-24 7:07 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 2,096 | $140.80 | $295,115.00 | (30%) 6.99K to 4.89K | |
04-Oct-23 5:07 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Oct-23 | Private Sale (Planned) | 1,437 | $112.68 | $161,921.00 | (23%) 6.33K to 4.89K | |
01-Sep-23 4:36 PM View: | Neurocrine Biosciences Inc. (NBIX) | 30-Aug-23 | Private Sale (Planned) | 2,733 | $107.60 | $294,058.00 | (44%) 6.19K to 3.46K | |
23-Aug-23 8:01 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 1,600 | $107.41 | $171,862.00 | (21%) 7.79K to 6.19K | |
08-Feb-23 7:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 700 | $104.11 | $72,876.00 | (13%) 5.46K to 4.75K | |
08-Feb-23 7:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 24,298 | $102.42 | $2,488,520.00 | (85%) 28.43K to 4.13K | |
08-Feb-23 7:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 240 | $105.61 | $25,346.20 | (5%) 4.37K to 4.13K | |
02-Feb-23 5:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 1,104 | $109.92 | $121,349.00 | (22%) 5.01K to 3.91K | |
02-Nov-22 6:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Oct-22 | Private Sale (Planned) | 1,295 | $114.12 | $147,785.00 | (31%) 4.21K to 2.92K | |
05-Oct-22 7:07 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Oct-22 | Private Sale (Planned) | 1,437 | $106.59 | $153,170.00 | (25%) 5.65K to 4.21K | |
09-Feb-22 8:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 700 | $79.62 | $55,736.00 | (19%) 3.62K to 2.92K | |
09-Feb-22 8:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 240 | $81.07 | $19,456.80 | (9%) 2.53K to 2.29K |